1-ethyl-6-fluoro-3-(2-(isoindolin-2-yl)ethyl)-1H-indol-4-ol → 1-ethyl-6-fluoro-3-(piperidin-3-yl)-1H-indol-4-ol
반응식
[CH2:1]([N:3]1[C:11]2[CH:10]=[C:9]([F:12])[CH:8]=[C:7]([OH:13])[C:6]=2[C:5]([CH2:14][CH2:15][N:16]2[CH2:24][C:23]3[C:18](=CC=CC=3)C2)=[CH:4]1)[CH3:2].C(N1CCCC(C2C3C(=CC(F)=CC=3OCC3C=CC=CC=3)N(CC)C=2)=C1)C1C=CC=CC=1>>[CH2:1]([N:3]1[C:11]2[CH:10]=[C:9]([F:12])[CH:8]=[C:7]([OH:13])[C:6]=2[C:5]([CH:14]2[CH2:18][CH2:23][CH2:24][NH:16][CH2:15]2)=[CH:4]1)[CH3:2]참가 물질
3
실험 절차
Following the procedure (step 3 scheme 31 used to prepare compound 31-4 compound 38-3 gave compound 38-4 (113 mg, 59%) as a light tan-colored solid. 1H NMR (300 MHz, MeOD-d6): δ (ppm) 6.80 (s, 1H), 6.49 (dd, J=10.0, 2.1 Hz, 1H), 6.13 (dd, J=11.4, 2.1 Hz, 1H), 4.01 (q, J=7.2 Hz, 2H), 3.53-3.40 (m, 2H), 3.05 (d, J=11.4 Hz, 1H), 2.55 (dt, J=23.0, 11.7 Hz, 2H), 2.14 (dd, J=8.8, 6.1 Hz, 1H), 1.85-1.56 (m, 3H), 1.34 (t, J=7.2 Hz, 3H). LCMS: calc 262.1 and found: 263.1 [MH]+.